Rare tuberculosis in recipients of allogeneic hematopoietic stem cell transplantation successfully treated with contezolid–a typical case report and literature review

Rare tuberculosis in recipients of allogeneic hematopoietic stem cell transplantation successfully treated with contezolid–a typical case report and literature review

BackgroundTuberculosis (TB) is a rare but potentially devastating complication in hematopoietic stem cell transplantation (HSCT) recipients. Myelosuppression-related antibiotics should be used cautiously in patients with hematological malignancies, especially those undergoing bone marrow transplanta...

Full description

Bibliographic Details
Main Authors:	Junhong Li, Zhaoxian Yu, Yingyi Jiang, Suihua Lao, Dexian Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-10-01
Series:	Frontiers in Cellular and Infection Microbiology
Subjects:	hematopoietic stem cell transplantation tuberculosis antibiotic therapy contezolid myelosuppression
Online Access:	https://www.frontiersin.org/articles/10.3389/fcimb.2023.1258561/full

Similar Items

Clinical Utility of Contezolid-Containing Regimens in 25 Cases of Linezolid-Intolerable Tuberculosis Patients
by: Wang J, et al.
Published: (2023-09-01)

In vitro activities of contezolid (MRX-I) against drug-sensitive and drug-resistant Mycobacterium tuberculosis
by: Huiru An, et al.
Published: (2023-10-01)

Tuberculosis patients with special clinical conditions treated with contezolid: three case reports and a literature review
by: Jun Wang, et al.
Published: (2023-12-01)

Compassionate Use of Contezolid for the Treatment of Tuberculous Pleurisy in a Patient with a Leadless Pacemaker
by: Kang Y, et al.
Published: (2022-08-01)

Antibacterial activity of the novel oxazolidinone contezolid (MRX-I) against Mycobacterium abscessus
by: Shan. Gao, et al.
Published: (2023-08-01)

Development and Validation of an LC-MS/MS Method for the Quantitative Determination of Contezolid in Human Plasma and Cerebrospinal Fluid
by: Guanxuanzi Zhang, et al.
Published: (2022-12-01)

Case report: Successful treatment with contezolid in a patient with tuberculous meningitis who was intolerant to linezolid
by: Zhe Xu, et al.
Published: (2023-10-01)

Sequential Therapy of Linezolid and Contezolid to Treat Vancomycin-Resistant Enterococcus faecium Pneumonia in a Centenarian Patient: Case Report
by: Chen P, et al.
Published: (2023-03-01)

Sequential Therapy of Linezolid and Contezolid to Treat Vancomycin-Resistant Enterococcus faecium Pneumonia in a Centenarian Patient: Case Report [Corrigendum]
by: Chen P, et al.
Published: (2023-03-01)

Use of Contezolid for the Treatment of Refractory Infective Endocarditis in a Patient with Chronic Renal Failure: Case Report
by: Zhao S, et al.
Published: (2023-06-01)

Contezolid-Containing Regimen Successfully Treated Multiple Drug Resistance Mycobacterium Abscessus Complex Infection of Skin: A Case Report and Literature Review
by: Gao X, et al.
Published: (2024-03-01)

Dose adjustment not required for contezolid in patients with moderate hepatic impairment based on pharmacokinetic/pharmacodynamic analysis
by: Junzhen Wu, et al.
Published: (2023-03-01)

Contezolid, a novel oxazolidinone antibiotic, may improve drug-related thrombocytopenia in clinical antibacterial treatment
by: Bi Li, et al.
Published: (2023-04-01)

Phosphate Metabolic Inhibition Contributes to Irradiation-Induced Myelosuppression through Dampening Hematopoietic Stem Cell Survival
by: Yiding Wu, et al.
Published: (2022-08-01)

Severe Community-Acquired Pneumonia Caused by Methicillin-Sensitive Staphylococcus aureus: Successfully Treated with Contezolid – A Case Report and Literature Review
by: Wang K, et al.
Published: (2023-05-01)

In vitro Activity of Contezolid Against Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococcus, and Strains With Linezolid Resistance Genes From China
by: Siheng Wang, et al.
Published: (2021-08-01)

Compassionate use of contezolid in a toddler with severe community-acquired pneumonia induced by staphylococcus aureus: a case report and follow-up
by: Hui-Ying Liu, et al.
Published: (2024-02-01)

Cholesterol confers ferroptosis resistance onto myeloid-biased hematopoietic stem cells and prevents irradiation-induced myelosuppression
by: Chaonan Liu, et al.
Published: (2023-06-01)

Hitting the snooze button: Inducing quiescence with the FLT3 inhibitor quizartinib protects hematopoietic progenitors from chemotherapy
by: Samuel J. Taylor, et al.
Published: (2017-11-01)

STS1 and STS2 Phosphatase Inhibitor Baicalein Enhances the Expansion of Hematopoietic and Progenitor Stem Cells and Alleviates 5-Fluorouracil-Induced Myelosuppression
by: Na Li, et al.
Published: (2023-02-01)

Single-Cell RNA Sequencing of Hematopoietic Stem and Progenitor Cells Treated with Gemcitabine and Carboplatin
by: Niclas Björn, et al.
Published: (2020-05-01)

Infections Caused by Mycobacterium tuberculosis in Recipients of Hematopoietic Stem Cell Transplantation
by: Khalid Ahmed Al-Anazi, et al.
Published: (2014-08-01)

A comparison of the effect of xinruibai versus filgrastim on hematopoietic reconstruction after allogeneic hematopoietic stem cell transplantation
by: Qixiang Ye, et al.
Published: (2018-05-01)

by: P.B. Soares, et al.
Published: (2013-01-01)

Secondary hemophagocytic lymphohistiocytosis related to hematopoietic tuberculosis
by: Naaima Zemed, et al.
Published: (2016-01-01)

Elevated Galectin-3 Plasma Concentrations in Recipients of Allogeneic Hematopoietic Cell Transplantation
by: Zachariah DeFilipp, et al.
Published: (2019-08-01)

Danggui Jixueteng decoction for the treatment of myelosuppression after chemotherapy: A combined metabolomics and network pharmacology analysis
by: Mingxin Guo, et al.
Published: (2024-02-01)

Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients
by: Lauren Stern, et al.
Published: (2019-05-01)

The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation From Different Donors in Recipients With Mucopolysaccharidosis
by: Yuhua Qu, et al.
Published: (2022-06-01)

Nutritional modulation of the gut microbiome in allogeneic hematopoietic stem cell transplantation recipients
by: Edoardo Muratore, et al.
Published: (2022-10-01)

Gold Nanoparticles Coated with SH-PEG-NH2 and Loaded with Ziyuglycoside I for Promoting Autophagy in Hematopoietic Stem Cells
by: Xiong Y, et al.
Published: (2023-03-01)

The Impact of the Epigenetic Cancer Drug Azacitidine on Host Immunity: The Role of Myelosuppression, Iron Overload and <i>tp53</i> Mutations in a Zebrafish Model
by: Shu-Ching Wang, et al.
Published: (2019-09-01)

Is It Better to Mobilize Hematopoietic Stem Cells With Pegfilgrastim in Healthy Donors During Allogeneic Hematopoietic Stem Cell Transplantation?
by: Jiali Li, et al.
Published: (2020-09-01)

Danggui Buxue decoction alleviates cyclophosphamide-induced myelosuppression by regulating β-hydroxybutyric acid metabolism and suppressing oxidative stress
by: Yiqiao Gao, et al.
Published: (2023-12-01)

Hematopoietic Effects of <i>Angelica gigas</i> Nakai Extract on Cyclophosphamide-Induced Myelosuppression
by: Mincheol Kang, et al.
Published: (2022-12-01)

Transcriptome Profiling Analysis Reveals the Potential Mechanisms of Three Bioactive Ingredients of Fufang E’jiao Jiang During Chemotherapy-Induced Myelosuppression in Mice
by: Xue Li, et al.
Published: (2018-06-01)

Mycobacterium tuberculosis-Specific IL-21+IFN-γ+CD4+ T Cells Are Regulated by IL-12.
by: Li Li, et al.
Published: (2016-01-01)

Mutations in the cytomegalovirus UL97 gene associated with ganciclovir resistance in recipients of allogeneic hematopoietic stem cell transplants
by: Demin M.V., et al.
Published: (2019-12-01)

Promotion of myelopoiesis in myelosuppressed mice by Ganoderma lucidum polysaccharides
by: Xiao Ling Zhu, et al.
Published: (2012-02-01)

Human Cytomegalovirus Infection Suppresses CD34<sup>+</sup> Progenitor Cell Engraftment in Humanized Mice
by: Lindsey B. Crawford, et al.
Published: (2020-04-01)